Will women soon have a Viagra of their own? Although a Food and Drug Administration advisory panel recently rejected an application to market the drug flibanserin in the United States for women with low libido, it endorsed the potential benefits and urged further research. Several pharmaceutical companies are reported to be well along in the search for such a drug.
The implication is that a new pill, despite its unforeseen side effects, is necessary to cure the sexual malaise that appears to have sunk over the country. But to what extent do these complaints about sexual apathy reflect a medical reality, and how much do they actually emanate from the anxious, overachieving, white upper middle class?
In the 1980s, commercial music boasted a beguiling host of sexy pop chicks like Deborah Harry, Belinda Carlisle, Pat Benatar, and a charmingly ripe Madonna. Late Madonna, in contrast, went bourgeois and turned scrawny. Madonna’s dance-track acolyte, Lady Gaga, with her compulsive overkill, is a high-concept fabrication without an ounce of genuine eroticism.
Pharmaceutical companies will never find the holy grail of a female Viagra — not in this culture driven and drained by middle-class values. Inhibitions are stubbornly internal. And lust is too fiery to be left to the pharmacist.
